UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.715

Sortiert nach

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

Nature communications, 2019-09, Vol.10 (1), p.4278-12, Article 4278

2019

Link zum Volltext

Verfügbarkeit prüfen

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nature communications, 2020-05, Vol.11 (1), p.2285-2285, Article 2285

2020

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

The Lancet (British edition), 2021-08, Vol.398 (10302), p.759-771

2021

Link zum Volltext

Verfügbarkeit prüfen

Covid-19 vaccine effectiveness during Omicron BA.2 pandemic in Shanghai: A cross-sectional study based on EMR

Medicine (Baltimore), 2022-11, Vol.101 (45), p.e31763-e31763

2022

Link zum Volltext

Verfügbarkeit prüfen

MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

European journal of immunology, 2020-11, Vol.50 (11), p.1810-1819

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab

Scientific reports, 2019-10, Vol.9 (1), p.14039-8, Article 14039

2019

Link zum Volltext

Verfügbarkeit prüfen

The interpretable machine learning model associated with metal mixtures to identify hypertension via EMR mining method

The journal of clinical hypertension (Greenwich, Conn.), 2024-02, Vol.26 (2), p.187-196

2024

Link zum Volltext

Verfügbarkeit prüfen

Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity

Nature communications, 2020-02, Vol.11 (1), p.951-951, Article 951

2020

Link zum Volltext

Verfügbarkeit prüfen

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.23-29

2020

Link zum Volltext

Verfügbarkeit prüfen

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Cancer, 2021-08, Vol.127 (16), p.3019-3028

2021

Link zum Volltext

Verfügbarkeit prüfen

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease

International journal of cancer, 2019-11, Vol.145 (9), p.2433-2439

2019

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Cancer, 2022-06, Vol.128 (11), p.2148-2158

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B

Cancer, 2024-05, Vol.130 (9), p.1693-1701

2024

Link zum Volltext

Verfügbarkeit prüfen

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3065-3076

2022

Link zum Volltext

Verfügbarkeit prüfen

Genomic landscape of acquired resistance to third‐generation EGFR tyrosine kinase inhibitors in EGFR T790M‐mutant non–small cell lung cancer

Cancer, 2020-06, Vol.126 (11), p.2704-2712

2020

Link zum Volltext

Verfügbarkeit prüfen

On the optimal redundancy allocation for multi-state series–parallel systems under epistemic uncertainty

Reliability engineering & system safety, 2019-12, Vol.192, p.106019, Article 106019

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer

PloS one, 2013-05, Vol.8 (5), p.e64816-e64816

2013

Link zum Volltext

Verfügbarkeit prüfen

KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer

Future oncology (London, England), 2019-04, Vol.15 (10), p.1057-1066

2019

Link zum Volltext

Verfügbarkeit prüfen

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

Investigational new drugs, 2020-04, Vol.38 (2), p.360-368

2020

Link zum Volltext

Verfügbarkeit prüfen

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2022-06, Vol.40 (17), p.1916-1928

2022

Link zum Volltext

Verfügbarkeit prüfen

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

Journal of cachexia, sarcopenia and muscle, 2021-10, Vol.12 (5), p.1144-1152

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer

European journal of immunology, 2021-04, Vol.51 (4), p.956-964

2021

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Journal of thoracic oncology, 2019-02, Vol.14 (2), p.193-202

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

BMC cancer, 2020-08, Vol.20 (1), p.727-727, Article 727

2020

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect

Cancer Immunology, Immunotherapy, 2021-05, Vol.70 (5), p.1203-1211

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.715

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.555)
Mit Volltextzugriff
(7.234)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.348)
Life Sciences & Biomedicine
(2.911)
Technology
(1.672)
Physical Sciences
(1.522)
Humans
(1.418)
Chemistry
(871)
Female
(856)
Male
(820)
Animals
(765)
Engineering
(764)
Materials Science
(705)
Materials Science, Multidisciplinary
(562)
Middle Aged
(534)
Oncology
(505)
Science & Technology - Other Topics
(478)
Adult
(468)
Physics
(446)
Aged
(408)
Mice
(372)
Biochemistry & Molecular Biology
(336)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Covid-19 vaccine effectiveness during Omicron BA.2 pandemic in Shanghai: A cross-sectional study based on EMR

MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab

The interpretable machine learning model associated with metal mixtures to identify hypertension via EMR mining method

Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Genomic landscape of acquired resistance to third‐generation EGFR tyrosine kinase inhibitors in EGFR T790M‐mutant non–small cell lung cancer

On the optimal redundancy allocation for multi-state series–parallel systems under epistemic uncertainty

Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer

KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect

Suchergebnisse filtern